NOVONIX Ltd (NVX) SEC Filings

NOVONIX Ltd (NVX) has entered into a strategic partnership memorandum of understanding with ACP Technologies, LLC to advance a fully domestic anode material supply chain for the North American battery industry. The non-binding MOU provides a framework to pursue collaborative projects and negotiate definitive agreements.

The collaboration combines ACPT’s proprietary processes for converting petroleum-derived feedstocks into engineered carbon precursors with NOVONIX’s expertise in synthetic graphite anode active materials, including pitch coated synthetic graphite for high-performance and fast-charging applications. Materials from the partnership are expected to support process validation, customer sampling, and qualification of new domestic feedstocks, although there is no assurance that definitive agreements or specific projects will proceed.

NOVONIX Ltd (NVX) reports that 68,107 new ordinary fully paid shares have been issued on September 15, 2026, for quotation on ASX as a result of performance rights converting under an employee incentive scheme. These additional shares form part of an existing quoted class and rank equally in all respects with existing ordinary shares.

Following this issue, total quoted ordinary shares are 997,852,692, while the company also has various unquoted performance rights, options, share rights, convertible notes and convertible debentures outstanding.

NOVONIX Limited (NVX) reports that a share price breach of the A$0.12 Floor Price under its funding agreement with YA II PN, Ltd has triggered an Amortisation Event. With US$35,000,000 outstanding under the convertible debenture facility, NOVONIX must pay US$7,000,000 in cash by September 21, 2026, reducing the outstanding amount to US$28,000,000. The company plans to fund this from existing cash, and additional 30‑day rolling amortisation payments may be required if the event continues.

Separately, NOVONIX reports progress with its lead customer: an initial mass production qualification C-sample of synthetic graphite anode active material met 12 of 14 specifications, with one unmet parameter within about 1% of the requirement. NOVONIX expects mass production sales to this customer to begin in the second half of 2027, subject to successful qualification.

NOVONIX Ltd (NVX) reported a larger half-year net loss as it continues to invest heavily in its Riverside synthetic graphite facility while still pre-revenue in its core battery materials business. For the six months ended June 30, 2026, the Group recorded a net loss of $24.6 million (vs $20.1 million in 2025) and negative operating cash flow of $23.1 million, leaving cash of $59.5 million and net current liabilities of about $2.5 million.

The auditor highlighted a material uncertainty about going concern, pointing to ongoing losses, cash burn, the need for additional funding, and the risk of cash redemptions under the Yorkville convertible debentures if share-price conditions trigger Amortization Events. At June 30, 2026, $35 million of Yorkville debentures remained outstanding and $33.1 million under the LGES notes, both classified as current.

Strategically, NOVONIX delivered a C-sample synthetic graphite anode to Panasonic and reaffirmed planned mass production in the second half of 2027, subject to qualification. The company raised capital via an A$20.7 million institutional placement and an A$0.96 million share purchase plan, and completed the divestiture of its Battery Technology Solutions unit to focus on North American synthetic graphite. NOVONIX’s growth plan is underpinned by substantial U.S. government support, including a $100 million DOE grant, $103 million in Section 48C tax credits, and a conditional DOE loan commitment of up to $754.8 million, though these remain contingent on meeting program conditions and project milestones.

Novonix Limited reports the issue of 171,591 new ordinary fully paid shares (ASX code NVX) following the exercise or conversion of performance rights under an employee incentive scheme. These new shares are additional securities in an existing quoted class and are intended to be quoted on ASX.

The shares are being issued for non-cash consideration, with the value per security estimated at AUD 0.150000. After quotation, total quoted ordinary shares will be 997,784,585, alongside several unquoted classes including performance rights, options, share rights, convertible notes and convertible debentures.

NOVONIX Limited is changing the ratio of its American Depositary Shares so that the current ratio of 1 ADS representing 4 ordinary shares will become 1 ADS representing 40 ordinary shares. This has the same effect as a one-for-ten reverse split of existing ADSs, with each 10 existing ADSs exchanged for 1 new ADS. The new ADS ratio is expected to become effective on 27 August 2026, and the ADSs will continue trading on Nasdaq under the ticker NVX. The change does not alter the number of NOVONIX ordinary shares on issue or affect the ordinary shares listed on the ASX. NOVONIX previously received notice that its ADSs were below Nasdaq’s US$1.00 minimum bid price for 30 consecutive business days and was given 180 calendar days to regain compliance. The ADS ratio change is intended to increase the per-ADS trading price and assist in regaining compliance, though there is no assurance this will occur.

NOVONIX Limited reported quarterly operational and cash flow details while progressing its strategic graphite anode active material business. The company delivered a mass-production C-sample of synthetic graphite AAM to Panasonic Energy, with internal testing indicating it meets specifications, and reaffirmed its target to begin mass production for Panasonic in the second half of 2027, subject to completion of qualification. It completed an institutional placement of A$20.7 million and raised A$0.96 million via a share purchase plan, and the U.S. Government certified the Riverside project in connection with a previously allocated US$103 million Section 48C tax credit. NOVONIX also closed the divestiture of its Battery Technology Solutions division.

For the quarter ended 30 June 2026, net cash used in operating activities was 8,642 $USD’000 and investing outflows were 2,441 $USD’000, while financing activities provided 13,226 $USD’000. Cash and cash equivalents were US$59.5 million, with estimated funding capacity of 6.9 quarters. Capital expenditures totaled 2,260 $USD’000, mainly for the Riverside facility, and related-party payments were US$281,000. The company has fully drawn US$40,000,000 in unsecured convertible debentures and a USD$30,100,000 real estate facility.

NOVONIX Ltd director Sharan Burrow reported acquiring 31,250 ordinary shares on 2026-07-22 in an "other" acquisition (transaction code J) at $0.16 per share. Following this transaction, Burrow directly holds 246,989 ordinary shares. The Rule 10b5-1 trading-plan checkbox is not marked.

Novonix Limited, a foreign private issuer, reported an update to director Sharan Burrow’s holdings. An issue of shares under the company’s Share Purchase Plan changed her direct relevant interest, and she now holds 246,989 ordinary shares and 195,938 share rights. No changes were reported to any related contracts, and it was confirmed that the interests were not traded during a closed period requiring prior written clearance.